Close Menu

Books in a Library

Association between Mannose-Binding Lectin 2 Gene Polymorphism and Liver Fibrosis in Patients with Chronic Viral Hepatitis

DOI: 
10.7727/wimj.2016.155

ABSTRACT

Objective: Mannose-Binding Lectin (MBL) has become a popular molecule in investigations on basic and clinical Gastroenterology and contributed to new approaches to the understanding of infectious and immune diseases associated with intestine and liver. The aim of the present study was to investigate the association between codon 54 polymorphisms in MBL2 gene coding MBL and predisposition to fibrosis in patients with viral Hepatitis B and C.

Methods: One hundred patients with chronic hepatitis (70 hepatitis B, 30 hepatitis C) who underwent liver biopsy and 100 healthy controls with no known chronic disease were included in the study. Patients in both viral hepatitis groups were divided into two groups according to their fibrosis scores with Ishak scoring system. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was applied to determine the MBL2 codon 54 polymorphism. For the statistical analysis, the level of significance was set at P < 0.05.

Results: No significant differences in allele frequencies for any polymorphism were observed between patients and controls, although the G allele was more frequent in the patient groups (p>0.05). In the comparison in terms of G and A alleles between two groups, hepatitis B patients in Group-II (group with high fibrosis score) were found to have a significantly higher frequency of A alleles (p=0.027).

Conclusion: Although it is accepted that MBL2 polymorphism play a part in the course of HBV and HCV infections, larger studies investigating the relation between MBL2 polymorphism and disease progression and treatment are required.

Accepted: 
25 May, 2016
PDF Attachment: 
e-Published: 14 Jul, 2016

Disclaimer

Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.

Top of Page